Please login to the form below

medicines

This page shows the latest medicines news and features for those working in and with pharma, biotech and healthcare.

We look forward to working with the accomplished Kumquat team to identify candidate medicines that interact with this target class,” he added.

BMS’ Q2 results beat expectations with strong performance across core therapy areas

We achieved significant clinical and regulatory milestones reflecting the hard work and dedication of our team, who together have built a portfolio of best-in-class medicines to meet the needs
GSK beats expectations thanks to strong vaccine sales in Q2

2021. Although GSK does not have an approved COVID-19 vaccine, its Sanofi-partnered candidate is currently being evaluated in phase 3 with a rolling review by the European Medicines Agency
Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb

Sales of Pfizer’s immunology medicine Xeljanz were down by 15%, driven partly by a negative impact on new patients starting the therapy following an ongoing US Food and Drug Administration
J&J and Pfizer quietly resolve Remicade biosimilar lawsuit

Janssen [J&J’s pharma division] has always been and remains committed to ensuring that our medicines – including Remicade – are accessible for patients and doctors who choose them.
CHMP rejects Kyowa Kirin’s Parkinson’s disease drug

The European Medicines Agency’s (EMA) Comittee for Medicinal Products for Human Use (CHMP) has rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant, despite the treatment being approved in the

More from news
Approximately 196 fully matching, plus 4,223 partially matching documents found.

Understanding the ‘real world’ starts and ends with the patient

For regularly misunderstood rare disease patients, such as those with PAH, this information is critical for developing medicines that may not only improve their prognosis but also their everyday lives.
Pre-launch planning and DSLs – the new ways to create launch excellence in pharma

Despite the global pandemic, in 2020 the European Medicines Agency (EMA) approved 39 new active substances, nine more than in 2019. ... efficacy, safety, pricing, medicine administration). Test messaging and language. o Engage and learn from the online
Pharma’s authentic proof of purpose influences decisions among HCPs and payers

of medicines and proactive collaboration with stakeholders to solve system challenges.
The power of the patient influencer

They may be advocating for their fellow patients behind the scenes, lobbying NICE for access to medicines, or publicising fundraising efforts via their local media.
Staying in the loop – six principles for impactful integrated communications

By connecting innovation in medicines with scientific collaboration and exchange, the pharmaceutical industry has a unique opportunity to unite all stakeholders, creating movements that transform outcomes.

More from intelligence
Approximately 27 fully matching, plus 616 partially matching documents found.

AZ appoints Susan Galbraith as executive vice president, oncology R&D

Over the past decade at AstraZeneca, she has developed new medicines that have transformed care and improved the lives of patients around the world,” said Pascal Soriot, chief executive officer of ... This ambition drives our bold strategy and pulls us
EFPIA confirms first and second vice-presidents

That includes working with governments to reduce access delays and improve the availability of medicines for patients across Europe. I look forward to working with the EFPIA Board and the wider
AZ appoints Alexion’s Aradhana Sarin as chief financial officer

Before embarking on her banking career, Sarin trained as a medical doctor in India and spent two years practising medicine in India and Africa.
CureVac taps Klaus Edvardsen for chief development officer role

Prior to that, he served as senior vice president and head of global medicines development oncology at AstraZeneca. ... He has also held leadership roles at GlaxoSmithKline (GSK) and at Genmab, working across medicines development within various
Nicky Hutchens appointed as deputy managing director at Four Health

address health inequalities and to ensure that life changing medicines are supported by our incredible industry. It’s a goal the team here at Four Health all share, and I am

More from appointments
Approximately 10 fully matching, plus 364 partially matching documents found.

Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

working to improve precision medicine and find cures for all known diseases, plus much more.
VISFO sees exponential growth as demand from pharma clients soars

With our roots firmly grounded in science and medicine, we’re well placed to serve the growing needs of the pharma industry, utilising our problem-solving approach to allow clients to
emotive supports Rare Disease Day 2019

On 20th February, we attended ‘The Unusual Suspects: Rare Diseases in Everyday Medical Care” at the Royal Society of Medicine, hosted by Medics 4 Rare Diseases (M4RD). . ... work we do in such an innovative area of medicine. .
Mednet Group’s growth spurt

ve settled in quickly with the team being so friendly and I’m looking forward to getting involved in a range of projects in the field of healthcare and medicine.”.
The 7 biggest risks to e-detailing success

E-detailers promote medicines to healthcare professionals (HCPs) over the phone and via online platforms, such as WebEx.

More from PMHub
Approximately 46 fully matching, plus 361 partially matching documents found.

Digital Engagement Strategist, Healthcare Brand Communications, ...: £75-90K

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

Digital Project Director, Healthcare Marketing Agency patient fo...: Highly competitive salary

Group Account Director, Patient focussed account, Healthcare com...: circa £90K

Project Director, Healthcare Marketing Agency patient focus Lond...: Highly competitive salary

Senior Consultant, Pricing & Market Access Consultancy, circ...: circa £100K package

No results were found

Add my company

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand: The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started: Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach: Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...

Email:
Password: